-
The FDA has approved the second of two new antiretroviral agents from new drug classes. Raltegravir is the first integrase strand transfer inhibitor and follows closely on the approval of maraviroc, a CCR5 co-receptor antagonist.
-
The 12-lead ECG and lead II rhythm strip seen in the Figure was obtained from an unfortunate middle-aged dialysis patient with a dilated cardiomyopathy. He had missed his last dialysis treatment.
-
-
Overweight employees who are paid to lose weight will do so in proportion to how much and how soon they are paid.
-
Coronary events occurred more commonly in patients who had experienced negative aspects of close relationships.
-
Diastolic blood pressures as low as 55mm Hg in the elderly were not found to be harmful when treating systolic hypertension; however, for those with known coronary heart disease, a minimum value of 70mm Hg is advised.
-
It has been demonstrated that women with metabolic syndrome (MBS) have a higher prevalence of sexual dysfunction.
-
Progress toward an effective HIV vaccine has encountered a major roadblock with the cessation of a HIV vaccine clinical trial sponsored by Merck & Co. Meanwhile, the need for an effective vaccine continues to grow: The number of new infections in 2006 rose to 4.3 million around the globe, 400,000 more than in 2004.
-
Your patients may be asking you about research news that indicates that use of oral contraceptives (OCs) increase cancer risk for women who use the method for more than eight years.
-
Officials at the District of Columbia Department of Health (DOH) are retooling the city's condom distribution program after meeting public resistance to its customized condoms.
